$インテリジェント・バイオソリューションズ(INBS.US)$Intelligent Bio - Cartridge and Reader Sales Are Expected to Increase 25% and 63%, Respectively, From July 1, 2023, Through to March 31, 2024
$インテリジェント・バイオソリューションズ(INBS.US)$Press Release: Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules Dow Jones· 7 mins ago
INBS CEO Harry Simeonidis is optimistic about the use of funds from the private placement, aiming to advance clinical trials for their Intelligent Fingerprinting Drug Screening System and broaden their market.
インテリジェント・バイオソリューションズに関するコメント
Hmm!
Update
Like!
Dow Jones· 7 mins ago
まだコメントはありません